ASHASHLAND INC.
Wholesale-Chemicals & Allied Products
- Revenue
- $1.8B
- 14% YoY
- Operating margin
- -42.5%
- 3353% YoY
- EBITDA
- −$538M
- 317% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- —
- $946M net debt
- AI in 10-K
- —
Red flags 2 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashFired27% of net incomeCash flow under 80% of net income
- Dilutive SBCClear1% of revenueOver 10% of revenue
- Payouts exceed cash flowFired131% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear15% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $2.1B | $2.4B | $2.2B | $2.1B | $1.8B | 14% |
| Operating income | $192M | $333M | $172M | −$26M | −$775M | 2881% |
| Operating cash flow | $466M | $193M | $294M | $462M | $134M | 71% |
| Capex | $105M | $113M | $170M | $137M | $98M | 28% |
| Stock-based comp | $15M | $18M | $22M | $15M | $14M | 6.7% |
| Buybacks | $450M | $200M | $300M | $380M | $100M | 74% |
| Dividends | $70M | $70M | $76M | $78M | $76M | 2.6% |
Deal filings
None.
13D filers
None on file.
Insider trading
No open-market trades in the last 12 months.
Pay vs performance
No pay-versus-performance disclosure yet.